Antimicrobial Potential of Commercially Produced Citronella Oil: An In Vitro and In Silico Investigation
This study presents the first report on the therapeutic potential of commercially produced citronella oil from Bangladesh as a dual-purpose antimicrobial and antiviral agent. The antifungal potential of citronella oil surpassed its antibacterial efficacy against the tested strains, and CID-91697 is recommended as a promising lead compound against SARS-CoV-2 according to the outcomes of in silico studies. These findings support further experimental and clinical validation of citronella oil as a sustainable, natural alternative for combating infectious diseases.
Authors
- Rizone Al Hasib (ORCID: https://orcid.org/0000-0003-3300-6751)
- Monira Akter Moni
- Mohammad Abu Hena Mostofa Jamal (ORCID: https://orcid.org/0000-0003-0542-4323)
- Zinia Afrin (ORCID: https://orcid.org/0000-0002-7552-9692)
- Md Ashikuzzaman Antor (ORCID: https://orcid.org/0000-0001-6637-3975)
- Abdel Halim Harrath
- Md Ataur Rahman
- Md. Mynul Islam
- Md. Jannatul Ferdous Parvez
- Shovon Shaha
Institutions
- Bangladesh Agricultural University (BD)
- King Saud University (SA)
- Islamic University (BD)
- The Barbara Ann Karmanos Cancer Institute (US)
Publication Details
- Journal
- Current Drug Targets
- Published
- 2026-01-02
- DOI
- https://doi.org/10.2174/0113894501395163251024061601
- Primary Topic
- Microbial Metabolism and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00